SCHEMBL14723642

SCHEMBL14723642

O=C(Nc1ccc(C#Cc2ccc(NC(=O)[C@@H]3CCCN3C(=O)Cc3ccccc3)cc2)cc1)[C@@H]1CCCN1C(=O)Cc1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.56
KDM4E B2RXH2 2/20 0.54
LMNA P02545 2/20 0.54
PABPC1 P11940 1/20 0.52
ITGB1 P05556 5/20 0.52
ITGA4 P13612 5/20 0.52
MEN1 O00255 1/20 0.51
NPC1 O15118 1/20 0.51
MAPT P10636 1/20 0.51
CASP3 P42574 1/20 0.51
RAB9A P51151 1/20 0.51
KMT2A Q03164 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
SENP7 Q9BQF6 1/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51
HSD17B10 Q99714 1/20 0.51
HCRTR1 O43613 2/20 0.50
HCRTR2 O43614 2/20 0.50
KDM1A O60341 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18887480 0.96 KDM4E (0.59) ALDH1A1KDM4ELMNAPABPC1ITGB1
SCHEMBL18887509 0.95 ALDH1A1 (0.54) ALDH1A1KDM4ELMNAPABPC1ITGB1
SCHEMBL18887481 0.92 ALDH1A1 (0.49) ALDH1A1KDM4ELMNAPABPC1ITGB1
SCHEMBL13379342 0.91 PABPC1 (0.67) ALDH1A1KDM4ELMNAPABPC1ITGB1
SCHEMBL18887528 0.90 HPGD (0.52) ALDH1A1KDM4ELMNAPABPC1ITGB1
SCHEMBL14723759 0.90 ALDH1A1 (0.59) ALDH1A1KDM4ELMNAPABPC1ITGB1
SCHEMBL13388285 0.89 ALDH1A1 (0.47) ALDH1A1KDM4ELMNAPABPC1ITGB1
SCHEMBL18887502 0.87 HIF1A (0.48) ALDH1A1KDM4ELMNAPABPC1HSD17B10
SCHEMBL12619063 0.87 ALDH1A1 (0.57) ALDH1A1KDM4ELMNAPABPC1ITGB1
SCHEMBL845226 0.86 ALDH1A1 (0.56) ALDH1A1KDM4ELMNAPABPC1ITGB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2328865-B1 HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2017-05-31 EP disclosed
EP-2328865-B1 HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2017-05-31 EP disclosed
US-8383094-B2 inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV); useful in establishing or determining the binding site of other antiviral compounds, for example, by competitive inhibition; used to treat or prevent viral contamination of materials BRISTOL-MYERS SQUIBB COMPANY (US) 2013-02-26 US disclosed